44714
(S)-Mevalonic acid lithium salt
≥96.0% (GC)
别名:
Lithium (S)-3,5-dihydroxy-3-methyl-pentanoate, Lithium (S)-3,5-dihydroxy-3-methyl-valerate, S-MVA-Li
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C6H12O4 · xLi+
化学文摘社编号:
分子量:
148.16 (free acid basis)
MDL number:
UNSPSC Code:
12352106
NACRES:
NA.25
产品名称
(S)-Mevalonic acid lithium salt, ≥96.0% (GC)
SMILES string
O[C@@](CCO)(CC(=O)O)C
InChI
1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/t6-/m0/s1
InChI key
KJTLQQUUPVSXIM-LURJTMIESA-N
assay
≥96.0% (GC)
optical activity
[α]/D +25.0±3.0°, c = 0.1 in 1 M HCl
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
Metabolite of the mevalonate pathway, which plays a key role in the biosynthesis of sterols, dolichol, heme and ubiquinone. Of interest for research in the disease areas oncology, autoimmune diseases, artherosclerosis and Alzheimer disease, as well as for inherited deficiencies of mevalonate kinase.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
R R Kopito et al.
Journal of lipid research, 23(4), 577-583 (1982-05-01)
A circadian rhythm in plasma mevalonate was identified in human subjects. This variation, over a 5-fold range, is paralleled by a rhythm in urinary excretion. No such diurnal change in plasma mevalonate was observed in schedule-fed, light-cycled rats, despite the
R A Larson et al.
Blood, 64(1), 257-262 (1984-07-01)
Mevalonic acid can stimulate leukemic cells from some patients with B cell chronic lymphocytic leukemia (CLL) to enter the cell cycle in vitro and to synthesize DNA. Unlike normal human peripheral blood lymphocytes, which require the presence of granulocytes for
Le-Le Hu et al.
PloS one, 6(12), e29491-e29491 (2012-01-06)
Given a compound, how can we effectively predict its biological function? It is a fundamentally important problem because the information thus obtained may benefit the understanding of many basic biological processes and provide useful clues for drug design. In this
Priti Agarwal et al.
The Journal of investigative dermatology, 135(4), 1080-1088 (2014-12-19)
Vitiligo is a common autoimmune disease of the skin that results in disfiguring white spots. There are no Food and Drug Administration (FDA)-approved treatments, and current treatments are time-consuming, expensive, and of low efficacy. We sought to identify new treatments
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持